Clinical Trials Directory

Trials / Unknown

UnknownNCT02492256

Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AF

Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Persistent Atrial Fibrillation Patients: Prospective Randomized Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Although circumferential pulmonary vein isolation (PVI) has been considered as the cornerstone for atrial fibrillation ablation, there has been a substantial recurrence rate. The investigators designed a prospectively randomized study to evaluate whether additional atrial ganglionated plexi ablation guided by the SUMO technology improves the clinical outcome in patients with persistent AF.

Conditions

Interventions

TypeNameDescription
DEVICEPulmonary vein isolationCARTO- reconstruction LA, preferably during same rhythm as SUMO map (generally sinus rhythm) for use during registration of SUMO map in CARTO. Conventional PVI by circumferential antral ablation according to standard procedures. Exit and Entrance block conformation. Attempt to induce sustained atrial tachycardia. Optional mapping and ablation of post-ablation atrial tachycardia.
DEVICEGP ablation guided by SUMO technologyCARTO- reconstruction LA, preferably during same rhythm as SUMO map (generally sinus rhythm) for use during registration of SUMO map in CARTO. High frequency stimulation (HFS; 20-Hz frequency, 5-ms pulse duration, and 15-mA output) to access positive vagal response (the heart rate decreasing by 50% at baseline). RF Ablation of SUMO hotspots (in sinus rhythm if AF converts) • Target a region of 1.0-1.5 cm diameter around the SUMO 'hotspot'. Control HFS. Attempt to induce sustained atrial tachycardia. Optional mapping and ablation of post-ablation atrial tachycardia.
DEVICEILR implantationImplantation the ECG loop recorder according to standard procedure

Timeline

Start date
2015-06-01
Primary completion
2016-05-01
Completion
2016-08-01
First posted
2015-07-08
Last updated
2015-07-08

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT02492256. Inclusion in this directory is not an endorsement.